A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non-Muscle Invasive Bladder Cancer

Protocol: 
AAAR2604
Phase: 
I/II

A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non-Muscle Invasive Bladder Cancer

Are you Eligible? (Inclusion Criteria)

1. 18 to 85 years of age at time of study enrollment.
2. Able to meet the requirements of the study, give voluntary, written
informed consent, and
must be able to adhere to dosing and visit schedules.
3. Has a diagnosis of low-grade (G1 or G2), uni- or multifocal papillary-
appearing bladder
tumor, stage Ta.

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States